Patients with a history of orthostatic hypotension.
Severe hepatic impairment.
Women, patients ≤21 years old (see Use in Pregnancy & Lactation).
Hypersensitivity to tamsulosin, dutasteride, other ingredients of the product or to other 5α-reductase inhibitors.